SavedAdd your journal

Journals / Akademik Gastroenteroloji Dergisi / 2011 / Cilt: 10 - Sayı: 3

Ornidazole-induced liver toxicity: Report of two cases

Ornidazol’e bağı karaciğer toksisitesi: İki olgu sunumu

Tolga KÖŞECİ
Ümit KARABULUT
Bünyamin SARITAŞ
Serkan YARAŞ
Fehmi ATEŞ
ENGİN ALTINTAŞ
Orhan SEZGİN
Pages
122–124
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we report two cases of drug-induced hepati- tis caused by ornidazole.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ornidazole is one of the nitroimidazole-derivative antibiotics and is of- ten used in daily practice.
📊
Key Findings & Data:Acute liver injury is the most common type of drug-induced hepatitis and accounts for 10% of acute hepatitis.
💡
Conclusion & Impact:Here, we report two cases of drug-induced hepati- tis caused by ornidazole.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Ornidazole is one of the nitroimidazole-derivative antibiotics and is of- ten used in daily practice. Hepatotoxicity caused by ornidazole is rare, but when it occurs, it can have serious results. Acute liver injury is the most common type of drug-induced hepatitis and accounts for 10% of acute hepatitis. Here, we report two cases of drug-induced hepati- tis caused by ornidazole.

Özet

Ornidazol günlük uygulamalarda sık kullanılan, nitroimidazol türevi an- tibiyotiklerdendir. Ornidazole bağlı toksik hepatit nadir olarak görül- mekte olup fakat ciddi sonuçları olabilen bir durumdur. Akut karaciğer hasarı ilaca bağlı karaciğer hasarının en sık görülen biçimidir ve akut hepatitilerin %10’luk kısmını oluflturur. Kliniğimizde ornidazol kullanı- mına ikincil toksik hepatit tanısı koyduğumuz iki olguyu sunuyoruz.

🔖

Cite This Article

KÖŞECİ, T., KARABULUT, Ü., SARITAŞ, B., YARAŞ, S., ATEŞ, F., ALTINTAŞ, E., SEZGİN, O. (2011). Ornidazole-induced liver toxicity: Report of two cases. Akademik Gastroenteroloji Dergisi, Cilt: 10 - Sayı: 3, 122–124. https://ajindex.com/articles/164361

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Koch-Weser J, Goldman P. Drug therapy: metronidazole. N Engl J Med 1980;303:1212-8
  2. Koflar Y, fiaflmaz N, O¤uz P, et al. Ornidazole-induced autoimmune hepatitis. Eur J Gastroenterol Hepatol 2001;13:737-9
  3. Ersöz G, Karasu Z, Akarca US, et al. Nitroimidazole-induced chronic hepatitis. Eur J Gastroenterol Hepatol 2001;13:963-6
  4. Tabak F, Özaras R, Erzin Y, et al. Ornidazole induce liver damage: report of three cases and review of the literature. Liver International 2003:23:351-4
  5. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-5
  6. Shapiro MA, Lewis JH. Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 2007;11:477-505
  7. Friis H, Andreasen PB. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 1992;232:133-8
  8. Pillans PI. Drug associated hepatic reactions in New Zealand: 21 years experience. N Z Med J 1996;109:315-9
  9. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002;22:145-55
  10. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924- 34
  11. Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis 2009;29:337-47
  12. Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007;25:1135-51
  13. Björnsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther 2006;79:521-8
  14. Reuben A. Hy's law. Hepatology 2004; 39:574-8
  15. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000;4:73-96
  16. Benichou C. Criteria of drug-induced liver disorders.Report of an International Consensus Meeting. J Hepatol1990;11:272-6
  17. Gearhart M O. Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity. Ann Pharmacother 1994;28:1177-81
  18. Garcia Rodriguez L A, Duque A, Castellsague J, et al. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol 1999;48:847-52
  19. Hay RJ. Risk/benefit ratio of modern antifungal therapy. Focus on hepatic reactions. J Am Acad Dermatol 1993;29:S50-4 20. Chien RN, Yang LJ, Lin PY, Liaw YF. Hepatic injury